Point72 Asset Sees Potential In Pernix Therapeutics (PTX); Steadfast Capital Bets On GrubHub (GRUB)


Shares of Pernix Therapeutics Holdings, Inc. (Nasdaq:PTX) soared more than 40% in after-hours trading Friday as Steven A. Cohen’s Point72 Asset Management, L.P. disclosed in a regulatory filing ( SC 13G ) with the Securities and Exchange Commission (SEC) a 5.8% stake (3,724,344 shares) in the company.

The specialty pharmaceutical company project to release its first quarter 2016 earnings report this week on Thursday, May 05, before the opening bell.

PTX stock touched a new 52-week low of $0.73 during the last trading session, finally closing at $0.75, down $0.029 (or -3.73%)

Pernix Therapeutics, which develops, manufactures, markets, and sells pharmaceutical products, has 63.90M Shares Outstanding, Market Capitalization (intraday) of $47.93M and PTX stock one-year range is between $0.73 and $7.10 per share



Hedge fund Steadfast Capital Management LP disclosed after the closing bell Friday in a SEC filing ( SC 13G ) a 5.1% stake (4,310,000 shares) in GrubHub Inc. (NYSE:GRUB)

The online and mobile food-ordering company expects to deliver its first quarter 2016 financial statement on Tuesday, May 3, before the market open.

GRUB stock closed at $26.22, down $0.04 (or -0.15%), and 1,027,562 of its shares exchanged hands during the day

GrubHub, which provides an online and mobile platform for restaurant pick-up and delivery orders in the United States, has 84.62M Shares Outstanding, Market Capitalization (intraday) of $2.22B and GRUB stock 52-week range is from $17.77 to $41.20 per share


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/